The development and optimization of in-house CAR T generation and manufacturing procedure

Calendar Icon - Evently Webflow Template
12 Oct
Clock Icon - Evently Webflow Template

About the Session

  1. A short introduction
  2. Generation and characterization of an in-house humanized CD19 CAR lentiviral vector in vitro and in preclinical animal model.
  3. Identification of a novel agent that serves as a soluble transduction enhancer.
  4. Driving CAR-T manufacture optimization process.
Are you ready?

Get Early Access to
BioCon Asia-ACGT Conference!